Results 91 to 100 of about 816,202 (285)

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Recip Pump on Unstable Condensate [PDF]

open access: yes, 2018
Case StudiesPump Design Conditions, Sealing/Packing System Design Features, Sealing/Packing System Failures, Pump Improvements, Conclusions and Lessons ...
Mascherpa, Luigi, Jakubiak, Jason
core   +1 more source

Comparative Analysis of Ventricular Repolarization in Patients with Type 1 Diabetes vs. Healthy Group and Patients Using Insulin Pump vs. Multiple Daily Injections

open access: yesEndocrinology Research and Practice
Objective: The frequency of cardiovascular mortality is increased in type 1 diabetes mellitus (T1DM). Both hyperglycemia and hypoglycemia increase the risk of cardiac complications.
Ekin Yiğit Köroğlu   +7 more
doaj   +1 more source

Biomass DNA: An Emerging Building Block for Advanced Materials

open access: yesAdvanced Materials, EarlyView.
Biomass DNA is rapidly emerging from its traditional role as a genetic blueprint to serve as a versatile abundant, highly programmable polymeric building block. This review highlights the transformation of macroscopic bulk biomass DNA into next generation of functional materials, spanning from dynamic hydrogels, sustainable bioplastics, and high ...
Yuwei Hu, Itamar Willner, Li Niu
wiley   +1 more source

Reduced Graphene Oxide Enhances the Vascular Organization and Contractile Performance of Fibrin‐Gelatin‐Based Engineered Cardiac Tissue

open access: yesAdvanced Materials Interfaces, EarlyView.
Fibrin–gelatin hydrogels functionalized with reduced graphene oxide create a mechanically stable and bioactive 3D environment for engineered cardiac tissue. The composite matrix promotes endothelial lumen formation, enhances sarcomeric protein expression, and increases contractile performance of embedded cardiomyocytes.
Christoph Kuckelkorn   +5 more
wiley   +1 more source

High Vibration Problem Resolution in Centrifugal Pump through Design Change [PDF]

open access: yes, 2016
Case StudyCase Study 4: The case study is about single stage API BB2 pump. Pump operates at the temperature of 355 degree C (671 degree F), rated for pumping 442 m3/hr of Hydro-treated VGO (Vacuum Gas Oil) and is driven by a steam turbine.
Singh, Navneet   +2 more
core   +1 more source

Insulin pumps [PDF]

open access: yesArchives of Disease in Childhood, 2003
T, Torrance, V, Franklin, S, Greene
openaire   +2 more sources

An Adipocyte MKK3–p38β Axis Preserves Insulin Responsiveness in Mice and Is Reciprocally Altered in Human Obesity

open access: yesAdvanced Science, EarlyView.
The adipocyte MKK3–p38β axis emerges as an adaptive stress‐response pathway during obesity. Human visceral adipose tissue analyses, adipocyte‐specific mouse models, and primary adipocytes show that the MKK3–p38β axis supports insulin responsiveness by restraining p70S6K‐dependent inhibitory IRS1 feedback and preserving AKT–GLUT4 signaling. This pathway
Edgar Bernardo   +20 more
wiley   +1 more source

Insulin pump use in Australia

open access: yes, 2012
Insulin pump use in Australia explores the number, characteristics and experiences of insulin pump users, using information from the National Diabetes Services Scheme and the first national survey of insulin pump users, conducted by the Australian ...

core  

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus

open access: yesСахарный диабет, 2010
Aim. To evaluate the importance of insulin pump therapy for the achievement of DM1 compensation in children of different age. Materials and methods. The study included 36 patients aged 5-18 years with DM1.
Nina Viktorovna Bolotova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy